Oncomine revealed that the mRNA levels of GPx1 and GPx4 were strongly elevated in ovarian cancer tissues compared to those in normal ovarian tissues, whereas SELENOP levels were decreased in ovarian cancer tissues (Figure 6B). This evidence concerns the gene GPX1 and ovarian cancer.